ProCE Banner Activity

Treatment Options for Advanced Melanoma From 5 Experts: An Online Tool

Tool

Did you receive a diagnosis of advanced melanoma? Use this Interactive Decision Support Tool to see treatment options from 5 melanoma experts by answering a series of multiple choice questions about your cancer.

Released: May 03, 2019

Expiration: May 01, 2020

No longer available for credit.

Share

Faculty

Michael Postow

Michael Postow, MD

Chief, Melanoma Service
Associate Attending Physician
Department of Medicine
Memorial Sloan Kettering Cancer Center
New York, New York

Michael B. Atkins

Michael B. Atkins, MD

Professor of Medicine
Harvard Medical School
Beth Israel Deaconess Medical Center
Boston, Massachusetts

Adil Daud

Adil Daud, MD

HS Clinical Professor,
Department of Medicine
(Hematology/Oncology)
University of California, San Francisco
Director, Melanoma Clinical Research
UCSF Helen Diller Family Comprehensive Cancer Center

Kim Margolin

Kim Margolin, MD

Professor of Medicine
Division of Oncology
Stanford University Medical Center
Stanford, California

Hussein Tawbi

Hussein Tawbi, MD

Associate Professor of Medicine
Division of Hematology/Oncology
Department of Medicine
University of Pittsburgh Cancer Institute
Pittsburgh, Pennsylvania

Provided by

Provided by Postgraduate Institute for Medicine

ProCE Banner

Supporters

This activity is supported by educational grants from

Merck Oncology

Novartis Pharmaceuticals Corporation

Partners

GRACE

ProCE Banner

MRF 2019

ProCE Banner

Program Director Disclosure

Program Director

Michael Postow, MD

Chief, Melanoma Service
Associate Attending Physician
Department of Medicine
Memorial Sloan Kettering Cancer Center
New York, New York

Michael Postow, MD: consultant/advisor/speaker: Bristol-Myers Squibb, Chugai, Eisai, Merck, Nektar, Novartis, Pfizer, Replimune; researcher: Bristol-Myers Squibb, Infinity, Merck, Novartis, RGenix.

Faculty Disclosure

Primary Author

Michael B. Atkins, MD

Professor of Medicine
Harvard Medical School
Beth Israel Deaconess Medical Center
Boston, Massachusetts

Adil Daud, MD

HS Clinical Professor,
Department of Medicine
(Hematology/Oncology)
University of California, San Francisco
Director, Melanoma Clinical Research
UCSF Helen Diller Family Comprehensive Cancer Center

Kim Margolin, MD

Professor of Medicine
Division of Oncology
Stanford University Medical Center
Stanford, California

Hussein Tawbi, MD

Associate Professor of Medicine
Division of Hematology/Oncology
Department of Medicine
University of Pittsburgh Cancer Institute
Pittsburgh, Pennsylvania